SureView Cervical Cytology System
Cervical Cancer Screening
CommercialActive
Key Facts
About Techcyte
Techcyte is a private, commercial-stage company offering an FDA-cleared and CE-IVDR-certified AI platform for digital pathology. Its flagship product, Techcyte Fusion, integrates anatomic and clinical pathology into a single software solution, featuring AI tools for tasks like cervical cytology screening, parasitology, and bacteriology analysis. The company has established strategic collaborations with major institutions like Mayo Clinic Platform and ESP BD, positioning itself as a key player in the digital diagnostics transformation. It operates on a diagnostics business model, generating revenue through its software platform and associated solutions.
View full company profileTherapeutic Areas
Other Cervical Cancer Screening Drugs
| Drug | Company | Phase |
|---|---|---|
| CerviRaksha HPV Test | Karkinos Healthcare | Market |
| ScreenYu Gyn® | Epitype | Unknown |
| Vitro HPV Screening Assay | Appolon Bioteck | Approved/Commercial |
| Alinity m HR HPV Assay | Abbott | Commercial Launch |
| Aptima® HPV Assay Primary Screening | Hologic | FDA Approved |